Morphosys Ag (MOR) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
MorphoSys AG has announced a merger squeeze-out with Novartis BidCo Germany AG offering a cash compensation of EUR 68.00 per share for the transfer of shares from minority shareholders. This action is pending approval at the MorphoSys AG Annual General Meeting and subsequent registrations in commercial registers. The court-appointed expert auditor has preliminarily affirmed the fairness of the compensation amount.
For further insights into MOR stock, check out TipRanks’ Stock Analysis page.